Utilizing the Crosstalk Among Aerosolized Phenformin , Methylene Blue, Photodynamic Therapy , Zinc and Potassium for Treating Severe COVID-19 Infection and Its Inflammatory Complication
Clinical trial NCT05003492 · UNKNOWN
Trial details
- NCT number
- NCT05003492
- Sponsor
- Amr kamel khalil Ahmed
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2021-10-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.